Envometinib - CAS 2952542-22-0

Envometinib (Compound B) is a dual MEK inhibitor that operates through deep cyclic inhibition (DCI) . It exhibits antitumor activity across various in vivo models and is applicable in researching RAS and RAF mutated cancers, such as colorectal cancer and melanoma.

MEK

MAPK

2952520

C23H27ClN4O6S

523

O=C1OC=2C=C(OC(=O)N(C)C)C=CC2C(=C1CC=3C=CC=C(NS(=O)(=O)NC)C3Cl)CN(C)C

-20°C

Ice Packs

Small Compound